Conticello, C., Romano, A., Fabro, V. D., Martino, E. A., Calafiore, V., Sapienza, G., . . . Raimondo, F. D. (2019). Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network. MDPI AG.
Chicago-stil citatConticello, Concetta, et al. Feasibility, Tolerability and Efficacy of Carfilzomib in Combination With Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network. MDPI AG, 2019.
MLA-referensConticello, Concetta, et al. Feasibility, Tolerability and Efficacy of Carfilzomib in Combination With Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network. MDPI AG, 2019.